Ignite Creation Date:
2024-05-06 @ 3:11 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04542876
Status:
COMPLETED
Last Update Posted:
2020-09-09
First Post:
2020-09-08
Brief Title:
Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection
Sponsor:
Aarogyam UK
Organization:
Aarogyam UK
Study Overview
Official Title:
Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection An Open Label Feasibility Study
Status:
COMPLETED
Status Verified Date:
2020-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The emergence of asymptomatic patients poses a significant challenge to the prevention and treatment of the epidemicThere have not been any treatment options that reduce the viral load or preventive options that reduce the risk of developing severe conditionsTherefore present feasibility study of the safety and efficacy of Guduchi Ghan Vati was conducted in asymptomatic patients with COVID-19
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None